This guideline has been initiated by the task force Autoimmune Blistering Diseases of the
European Academy of Dermatology and Venereology, including physicians from all relevant …

Ocular mucous membrane pemphigoid (MMP) is a rare, immuno-mediated chronic
progressive condition of the conjunctiva characterized by blisters develo** from sub …

The aim of the treatment in autoimmune blistering diseases (AIBDs) is to induce and
maintain remission, which clinically corresponds to the cessation of new vesicle formation …

Subepidermal (subepithelial) autoimmune blistering dermatoses are a group of rare skin
disorders characterized by the disruption of the dermal-epidermal junction through the …

Background and Objectives: Linear IgA disease (LAD) is a rare autoimmune blistering
disease with linear IgA deposits along the basement membrane zone. Direct …

In this concept paper, the authors present a unique and novel protocol to treat autoimmune
diseases that may have the potential to reverse autoimmunity. It uses a combination of B cell …

Rituximab is a monoclonal antibody targeting CD20 on B cells with proven efficacy for
pemphigus vulgaris, now an FDA-approved indication. Other autoimmune bullous diseases …

Abstract Purpose of Review Rituximab has transformed the treatment of B-cell malignancies
and rheumatoid arthritis in the past 2 decades. More recently, this anti-CD20 monoclonal …

Mucous membrane pemphigoid (MMP) is a rare group of heterogeneous chronic
autoimmune diseases that predominantly manifest as blistering of the mucous membranes …

Intravenous Ig (IVIg) is used to treat mucous membrane pemphigoid, although its therapeutic
effectivity is not sufficiently supported by randomized controlled clinical trials, and its mode of …